Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

NCT05136820 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.

NCT NCT05136820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05136820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
Lead sponsor
Occlutech International AB
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 9, 2023
Completion date
February 28, 2029
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction (hfpef), heart failure with reduced ejection fraction (hfref)